F&C Asset Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

F&C Asset Management’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	$6.99M	Sell	130,799 -54,682	-29%	-$1.8M	0.09%	281
2013 Q4	$4.67M	Sell	185,481 -3,950	-2%	-$94.1K	0.06%	333
2013 Q3	$5.16M	Buy	189,431 +34,423	+22%	+$1.11M	0.07%	319
2013 Q2	$5.68M	Buy	+155,008	New	+$5.81M	0.08%	308

Other funds holding PTX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Sageview Capital Greenwich, Connecticut $177M AUM 36.56% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

EWP

Edmunds White Partners Richmond, Virginia $69.2M AUM 56.3% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

F&C Asset Management's PTX Position: Q1 2014 in Review

F&C Asset Management reduced its Pernix Therapeutics Holdings, Inc. (PTX) stake by 29% in Q1 2014, selling an estimated $1.8M and leaving 130,799 shares worth $6.99M. The position accounts for 0.09% of the portfolio, ranked #281.

F&C Asset Management first reported a position in PTX in Q2 2013 and has held it in 4 quarters since. 63 funds tracked by Wall St. Rank hold PTX as of Q1 2014.

F&C Asset Management held 130,799 shares of Pernix Therapeutics Holdings, Inc. worth $6.99M as of Q1 2014.
F&C Asset Management sold 54,682 Pernix Therapeutics Holdings, Inc. shares in Q1 2014, an estimated $1.8M.
Pernix Therapeutics Holdings, Inc. made up 0.09% of F&C Asset Management's portfolio in Q1 2014, its #281 holding.
F&C Asset Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and has held it in 4 quarters since.
63 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2014.

Based on F&C Asset Management's 13F filing for Q1 2014, filed 14 May 2014.